Trenbolone hexahydrobenzylcarbonate
Trenbolone hexahydrobenzylcarbonate, or trenbolone cyclohexylmethylcarbonate, sold under the brand names Parabolan and Hexabolan, is a synthetic, injected anabolic–androgenic steroid of the nandrolone group and an androgen ester – specifically, the C17β hexahydrobenzylcarbonate ester of trenbolone – which was marketed in France for medical use in humans but has since been discontinued.
It was introduced in France in 1980 and was voluntarily discontinued by its manufacturer in 1997. The drug acts as a long-lasting prodrug of trenbolone when administered via intramuscular injection. It was used clinically at a dosage of one ampoule every 10 days.
